Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 and calcitriol for vascular calcification in chronic kidney disease
ACTRN12610000815066Phase 4Not yet recruiting
- Sponsor
- SouthernBiotech
- Start
- Nov 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vitamin d and calcitriol in chronic kidney disease (CKD) (3 arms), sponsored by SouthernBiotech. Primary endpoint: Progression and incidence of coronary artery calcification. Planned start Nov 2010; status: not yet recruiting.
02
Drugs
vitamin dcalcitriol
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ACTRN12610000815066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000815066.